TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 21nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 97nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 210nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 300nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 1.07E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: 1.24E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: 1.31E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 1.42E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 1.48E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 1.57E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 1.94E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 2.06E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 2.12E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 2.57E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 3.13E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 5.37E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: 5.94E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: 6.38E+4nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
TargetAnoctamin-1(Homo sapiens (Human))
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Industry-Academic Cooperation Foundation Yonsei University
US Patent
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair
Affinity DataIC50: >1.00E+5nMAssay Description:The method for inhibiting the expression of ANO1 (TMEM16A) of the present disclosure includes a step of inhibiting the expression of ANO1 (TMEM16A) i...More data for this Ligand-Target Pair